Abivax Stock Guidance

ABVXNASDAQ

$7.88

1.4522.55%

Pre-Market: 9:20 AM EDT

FY 2024 Earnings in 13 days from now on Mon Mar 24th, after the market close

Guidance

Abivax issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

There have been no specific sales or earnings guidance reported for Abivax in recent months.

Browse guidance and forecast on all stocks.